Abstract
In the present study are reported the differential DNA binding activity of the anti-tumor polyamidine tetra-p-amidinophenoxyneopentane (TAPP-H) and its 2'-halo derivative (TAPP-Br), and their effects on the binding of the recombinant Epstein-Barr virus (EBV) nuclear antigen to a synthetic oligonucleotide mimicking the target DNA sequence present in the EBV genome. In addition, the proliferation kinetics and cell cycle analysis of human leukemia K562 cells treated with TAPP-H and TAPP-Br are reported. The possible in vivo relationship between DNA binding affinity and cytotoxicity is also discussed.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, Viral / chemistry
-
Antigens, Viral / metabolism*
-
Base Sequence
-
Benzamidines / pharmacology*
-
Cell Cycle
-
Cell Division / drug effects
-
DNA, Viral / metabolism*
-
DNA-Binding Proteins / chemistry
-
DNA-Binding Proteins / metabolism*
-
Diminazene / analogs & derivatives
-
Diminazene / pharmacology
-
Dose-Response Relationship, Drug
-
Epstein-Barr Virus Nuclear Antigens
-
Humans
-
Molecular Sequence Data
-
Tumor Cells, Cultured / drug effects
Substances
-
Antigens, Viral
-
Benzamidines
-
DNA, Viral
-
DNA-Binding Proteins
-
Epstein-Barr Virus Nuclear Antigens
-
1,3-di-(4-amidinophenoxy)-2,2-bis-(4-amidinophenoxymethyl)propane
-
4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide
-
diminazene aceturate
-
Diminazene